Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(3)

Detailed Status

Completed3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed3100%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Telemedicine to Improve Use of Therapeutic Hypothermia in Rural Settings

NCT03706417
completednot_applicable

Evaluating a Telemedicine Neurological Consult Program for Drug-Induced Movement Disorders Using the RE-AIM Framework

NCT06060444
completednot_applicable

Telemedicine to Reduce Disparities in the Identification and Treatment of Neonatal Encephalopathy

NCT05155111

Clinical Trials (3)

Showing 3 of 3 trials
NCT03706417Not Applicable

Telemedicine to Improve Use of Therapeutic Hypothermia in Rural Settings

Completed
NCT06060444Not Applicable

Evaluating a Telemedicine Neurological Consult Program for Drug-Induced Movement Disorders Using the RE-AIM Framework

Completed
NCT05155111Not Applicable

Telemedicine to Reduce Disparities in the Identification and Treatment of Neonatal Encephalopathy

Completed

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3